Skip to content

Optimizing Dysphagia Treatment Delivery in Acute Care: A Hybrid Efficacy Implementation Trial

Optimizing Dysphagia Treatment Delivery in Acute Care: A Hybrid Efficacy Implementation Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07736105
Enrollment
120
Registered
2026-07-30
Start date
2027-04-01
Completion date
2029-02-01
Last updated
2026-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysphagia, Critical Illness

Keywords

Dysphagia, Swallowing, Deglutition, Deglutition Disorders, Swallowing Disorders, Breathing, Cough, Critical Illness, Treatment

Brief summary

This research study is investigating the efficacy and implementation of expiratory muscle strength training (EMST), standard of care dysphagia treatment, and intensive dysphagia treatment in critically ill adults in the acute care setting. Currently, no targeted, effective, and feasible dysphagia treatment approaches currently exist for use in critically ill adults in the acute care setting. The current study will investigate the impact of EMST, standard of care dysphagia treatment, and intensive dysphagia treatment on pulmonary function, cough function, swallow function, frailty, patient-reported swallow function, and health outcomes in critically ill adults. This study will also examine patient perceptions and clinical speech-language pathologists' perceptions of the acceptability, appropriateness, and feasibility of these interventions. Critically ill adults will: undergo tests of breathing, cough, and swallow function, complete questionnaires about the treatment, and their swallow function, and complete their respective treatment as prescribed. Clinical speech-language pathologists will complete questionnaires about the interventions. A subset of critically ill adults and clinical speech-language pathologists will also have the opportunity to participate in focus groups.

Detailed description

This study will involve two in-person research evaluations in the hospital that will last 45 minutes- 1 hour and will consist of a screening, breathing and cough testing, swallow function testing, measures of frailty, and completion of questionnaires. Following the initial research evaluation, critically ill adults will complete the intervention they are assigned to as prescribed. The exercises will take 15-20 minutes to complete and adherence to treatment will be tracked. Prior to hospital discharge and after completion of the intervention, critically ill adults will undergo a second research evaluation. Clinical speech-language pathologists will complete questionnaires about the interventions that will take 10-15 minutes. A subset of critically ill adults and clinical speech-language pathologists will also have the opportunity to participate in focus groups, which will take 45 minutes-1 hour.

Interventions

EMST devices will be set to 60% of participants' maximum expiratory pressure. Participants will complete training 5 days per week by performing 5 sets of 5 repetitions.

BEHAVIORALStandard of Care Dysphagia Treatment

Critically ill adults will perform one set of ten repetitions of each exercise recommended by their clinical speech-language pathologist. Enrolled participants will complete up to two training sessions per week (0-2 pending normal clinical care course) with a clinical speech-language pathologist

BEHAVIORALIntensive Dysphagia Treatment

Critically ill adults will perform one set of ten repetitions of each exercise (effortful swallow, Masako maneuver, Mendelsohn maneuver, chin tuck against resistance, tongue strengthening exercises, and may also participate in bolus driven therapy). Enrolled participants will complete five training sessions per week (at least 3 days/week with the PI or a trained member of the research team and up to 2 days/week with a member of the clinical speech-language pathology team).

Sponsors

Vanderbilt University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

for critically ill adults will be: 1. Adult ≥ 18 years old 2. Not pregnant 3. Underwent a clinical flexible endoscopic evaluation of swallowing (FEES) or videofluoroscopy swallow study (VFSS) with a penetration aspiration scale (PAS) score ≥ 5 4. Hospitalized in non-neuro intensive care unit (ICU) setting at Vanderbilt University Medical Center (VUMC) at some point during admission 5. Dysphagia is primarily related to ICU stay and not other medical conditions that may cause dysphagia 6. medically cleared with no contraindications for expiratory muscle strength training (EMST) or other treatments 7. Cognitive capacity to follow basic directions 8. Willing to undergo testing and treatment for the study. Inclusion criteria for speech-language pathologists (SLPs) will be: 1. Adult acute care speech-language pathologist who works at VUMC. 2. Willing to complete surveys and/or participate in a focus group.

Design outcomes

Primary

MeasureTime frameDescription
Change in Penetration Aspiration Scale Scorespre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeksThe penetration aspiration scale is a validated 8-point ordinal rating scale that measures the depth of airway invasion and the patient's response during swallowing. Scores range from 1 to 8 with a score of 1 indicating a safe swallow (best score) and 8 indicating silent aspiration (worst score).
Change in Dynamic Imaging Grade of Swallowing Toxicity Scale (DIGEST) Gradespre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeksThe DIGEST is a validated, 5-point ordinal rating scale that quantifies global pharyngeal swallow function.

Secondary

MeasureTime frameDescription
Acceptability of Intervention Measure (AIM)post-treatment prior to hospital discharge, assessed up to 2 weeksA measure of how acceptable an intervention is with scores ranging from 4-20.
Change in Swallowing and Eating Related Fatigue Questionnaire (SERF)pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeksScores on the SERF range 0-48 with higher scores indicating greater impairment.
Change in Screening for Oral Frailty Tool (SOFT)pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeksOral frailty will be assessed as present/absent using the Screening for Oral Frailty Tool.
Change in Eating Assessment Tool 10 (EAT-10)pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeksThe EAT-10 contains 10 questions (score range: 0-40), higher scores indicate greater impairment.
Change in maximum expiratory pressurepre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeksA measure of respiratory strength while breathing out
Change in cough peak expiratory flowpre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeksA measure of cough strength
Intervention Appropriateness Measure (IAM)post-treatment prior to hospital discharge, assessed up to 2 weeksA measure of how appropriate an intervention is with scores ranging from 4-20.
Grip strengthpre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeksChange in Grip strength be used to quantify clinical frailty using a digital hand dynamometer.
Feasibility of Intervention Measure (FIM)post-treatment prior to hospital discharge, assessed up to 2 weeksA measure of how feasible an intervention is with scores ranging from 4-20.

Countries

United States

Contacts

CONTACTCara Donohue, PhD CCC-SLP
cara.donohue@vumc.org615-852-5085
PRINCIPAL_INVESTIGATORCara Donohue, PhD CCC-SLP

Vanderbilt University Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 10, 2026